NASDAQ:SABS | P/S Ratio | SAB Biotherapeutics, Inc.

Historical market capitalization divided by trailing-four-quarter filed revenue.

Available history
2021-12-31 to 2024-06-30
Data captured

Historical P/S Ratio

DateP/S Ratio
2024-06-3010.29
2024-03-3116.1
2023-12-3128.35
2023-09-3080.49
2023-06-3067.66
2023-03-3117.49
2022-12-311.24
2022-09-309.2
2022-06-3014.22
2022-03-3128.97
2021-12-3155.79

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.